Items

• Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future (2015-05)

  B. Godman, M. Wilcock, A. Martin, S. Bryson, C. Baumgartel, T. Bochenek, W. de Bruyn, L. Sović-Brkičić, M. D'Agata, A. Fogele, A. Coma Fuste, J. Fraeyman, J. Furst, K. Garuoliene, H. Herholz, M. Hoffman, S. Jayathissa, H. Kwon, I. Langner, M. Kalaba, E. Magnusson, E. Anderse Karlssen, O. Laius, V. Marković Peković, E. Magnusson, S. McTaggart, H. Pedersen, J. Piessnegger, A. Ringerud, G. Selke, C. Sermet, K. Schiffers, P. Skiold, D. Tomek, A. Viksna, A. Vitry, C. Zara, R. Malmstrom, Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future, Generics and Biosimilars Initiative Journal, Vol. 4, No. 3, pp. 125 - 135, May, 2015

• Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

  V. Marković Peković, R. Škrbić, A. Petrović, V. Vlahović-Palčevski, J. Mrak, M. Bennie, J. Fadare, H. Kwon, K. Schiffers, I. Truter, B. Godman, Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 16, No. 5, pp. 609 - 618, Oct, 2016